|
|||||
A new enterprise that offers electronic health service prescriptions is raising $1.8 million in seed funds and starting a program for prescribing digital health services simultaneously to groups of people. . . . → Read More: Start-Up Offers Digital Health Prescriptions, Raises $1.8M 
A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies. . . . → Read More: Scientists, Investors Form $100M+ Tech Venture Fund  Comments are closed  Finance  biomedical, engineering, entrepreneurs, equity, Europe, investment, life sciences, physical sciences, physics, U.K., university, venture capital 
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing. . . . → Read More: Genomics-Blockchain Company Launches, Raises $4.3 Million One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, blockchain, computer science, engineering, entrepreneurs, equity, genomics, investment, life sciences, medical device, software, university, venture capital 
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies 2 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences 
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, investment, licensing, life sciences, pharmaceuticals 
A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments Comments are closed Finance, Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, stem cells, university, venture capital 
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, investment, life sciences, pharmaceuticals 
Our reporting on venture capital, much like other business media, tells about the companies investing in early-stage enterprises, but what about the people in the industry? . . . → Read More: Infographic – Harvard or Stanford? Venture Capitalists Revealed. 
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled 2 comments - (Comments are closed) Finance, Intellectual property biomedical, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, stem cells, university, venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
